Toby Maher, MD, PhD, professor of clinical medicine, Keck Medicine of USC, discusses the impact of changes in lung function in patients with idiopathic pulmonary fibrosis (IPF). How does the rate of ...
A pair of studies presented at the European Respiratory Society Congress 2024 emphasized the importance of close monitoring and proactive treatment approaches for patients with idiopathic (IPF) and ...
Please provide your email address to receive an email when new articles are posted on . Nintedanib slows the rate of forced vital capacity decline in patients with fibrosing autoimmune disease-related ...
Background The relationship of social determinants of health (SDOH), environmental exposures and medical history to lung function trajectories is underexplored. A better understanding of these ...
Better lung function, expressed as higher forced vital capacity (FVC), is associated with a reduced risk for the onset of heart disease, diabetes, and stroke over a follow-up period of approximately ...
Dose-ranging trial evaluated deupirfenidone 550 mg three times a day (TID) (approximately equivalent exposure to pirfenidone 801 mg TID 1) and deupirfenidone 825 mg TID and successfully demonstrated ...
Bexotegrast-treated patients demonstrated improvements in forced vital capacity (FVC) and reduced cough severity compared to placebo. Bexotegrast was well tolerated at 160 mg over 12 weeks of ...
Please provide your email address to receive an email when new articles are posted on . In a multicenter, longitudinal cohort study, Regan and colleagues evaluated 10,198 current/former smokers with a ...
A large study of 35,000 children from eight countries has found a 'robust' link between exposure to green spaces in early childhood and better lung function. The study used data from 10 European birth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback